JAMES CANNER: Open Payments
NPI 1568126639 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,112 in 259 payments from 25 companies in 2025. Trend: 2023 $1,248 · 2024 $6,248 · 2025 $9,112
Food & beverage: $7,864Consulting: $1,233Education: $15
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 24 | $2,603 |
| ABBVIE INC. | 49 | $1,172 |
| GENZYME CORPORATION | 22 | $977 |
| Galderma Laboratories, L.P. | 28 | $863 |
| UCB, Inc. | 19 | $463 |
| LEO Pharma Inc. | 15 | $439 |
| Amgen Inc. | 9 | $403 |
| Organon LLC | 6 | $372 |
| Botanix SB Inc | 13 | $268 |
| Incyte Corporation | 10 | $211 |
Products named: DUPIXENT, RINVOQ, NEMLUVIO, SKYRIZI, Bimzelx, VTAMA, ANZUPGO, SOFDRA.
Industry payments across NY — which companies pay providers there.
